These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38126073)

  • 21. Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants.
    Alkhafaji AA; Trinquart L; Baron G; Desvarieux M; Ravaud P
    BMC Med; 2012 Nov; 10():142. PubMed ID: 23167972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Contrasting Perceptions and the Cause Regarding Patenting Technologies Between Academic Medical Researchers and Pharmaceutical Companies Based in Japan.
    Sugimitsu K; Manome Y
    J Multidiscip Healthc; 2021; 14():1795-1805. PubMed ID: 34285498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes to intellectual property policy in South Africa: putting a stop to evergreening?
    Hill JE
    Expert Opin Ther Pat; 2014 Aug; 24(8):839-43. PubMed ID: 24965317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. May your drug price be evergreen.
    Feldman R
    J Law Biosci; 2018 Dec; 5(3):590-647. PubMed ID: 31143456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Summoning a New Artificial Intelligence Patent Model: In The Age Of Pandemic.
    Yanisky-Ravid S; Jin R
    SSRN; 2020 Jun; ():3619069. PubMed ID: 32714121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global patent landscape of programmed cell death 1: implications of the rapid expansion.
    Kong X; Zhang Q; Lai Y; Hu H; Chen X; Hu Y
    Expert Opin Ther Pat; 2018 Jan; 28(1):69-80. PubMed ID: 28891360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A patent perspective on chikungunya.
    Dapurkar D; Telang M
    Acta Trop; 2019 Nov; 199():105131. PubMed ID: 31401192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An empirical analysis of primary and secondary pharmaceutical patents in Chile.
    Abud MJ; Hall B; Helmers C
    PLoS One; 2015; 10(4):e0124257. PubMed ID: 25915050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open Innovation or Traditional Patenting Strategies to Efficiently Address Health Emergencies? How Patent Information Was Used Towards Effective Treatments for COVID-19.
    de Almeida TDME; Cordeiro DS
    Recent Pat Biotechnol; 2024 Jun; ():. PubMed ID: 38910270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. University patenting and licensing practices in the United Kingdom during the first year of the COVID-19 pandemic.
    Keestra S; Rodgers F; Osborne R; Wimmer S
    Glob Public Health; 2022 May; 17(5):641-651. PubMed ID: 35298347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patent term extensions: issues, challenges and implications for pharmaceuticals.
    Clark L; Beadle D
    Pharm Pat Anal; 2012 Sep; 1(4):427-35. PubMed ID: 24236881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement.
    Gleeson DH; Moir H; Lopert R
    Med J Aust; 2015 Apr; 202(6):306-8. PubMed ID: 25832153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective Strategies to Patent Plastic Surgery Ideas and Intellectual Property.
    Xu HH; Kazan R; Zammit D; Reece E; Jowett N; Gilardino MS; Vorstenbosch J
    Plast Reconstr Surg; 2023 May; 151(5):875e-884e. PubMed ID: 36728928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.
    Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J
    Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
    Jannuzzi AH; Vasconcellos AG; de Souza CG
    Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in intellectual property rights protection for medical cannabis and related products.
    Wyse J; Luria G
    J Cannabis Res; 2021 Jan; 3(1):1. PubMed ID: 33526141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Private and public values of innovation: A patent analysis of synthetic biology.
    Ribeiro B; Shapira P
    Res Policy; 2020 Feb; 49(1):103875. PubMed ID: 32015589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patenting DNA.
    Bobrow M; Thomas S
    Curr Opin Mol Ther; 2002 Dec; 4(6):542-7. PubMed ID: 12596355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyzing the Morality of Owning and Suspending Patent Rights for COVID-19 Vaccines in the Light of Catholic Social Teaching.
    Ballano VO
    Linacre Q; 2022 Feb; 89(1):47-63. PubMed ID: 35321490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.